Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

124.25 -1.64 (-1.30%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,502,023
Open 125.30
Bid (Size) 124.25 (13)
Ask (Size) 124.50 (10)
Prev. Close 125.89
Today's Range 122.37 - 125.59
52wk Range 99.14 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 2.35%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits
Merck secures legal victory as 3rd U.S. Circuit Court of Appeals upholds dismissal of 1,200 lawsuits over Zostavax shingles vaccine. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Merck & Co's Options Frenzy: What You Need to Know
Via Benzinga

Performance

YTD
+9.72%
+9.72%
1 Month
-2.92%
-2.92%
3 Month
-0.78%
-0.78%
6 Month
+4.82%
+4.82%
1 Year
+17.27%
+17.27%

More News

Read More
2 Magnificent Stocks to Buy With $500
Via The Motley Fool
Evaluating Merck & Co Against Peers In Pharmaceuticals Industry
Via Benzinga
3 Top Cancer Treatment Stocks to Buy Now
Via InvestorPlace
NYSE:MRK is probably undervalued for the fundamentals it is displaying.
Via Chartmill
Merck's Acquisition of EyeBio Finalized
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Merck & Co Stock
Via Benzinga
Merck & Co Unusual Options Activity
Via Benzinga
3 Biotech Stocks to Buy in Case of Another Pandemic
Via InvestorPlace
Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024
From Merck & Co., Inc.
Via Business Wire
Forget Nvidia: Billionaires Are Dumping It and Piling Into These 3 Surprising Value Stocks Instead
Via The Motley Fool
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Positive News is Driving This Cancer Drug Maker’s Stock Higher
Via MarketBeat
Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars
Via Benzinga
Merck Completes Acquisition of EyeBio
From Merck & Co., Inc.
Via Business Wire
3 Under-$10 Biotech Stocks That Could Make You Rich
Via InvestorPlace
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
Via InvestorPlace
S&P 500 2024 Q2 Earnings Preview: Aggregate Earnings Reaching A New High Watermark?
Via Talk Markets
Topics Stocks
Exposures US Equities
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
Via MarketBeat
Merk Animal Health Completes Acquisition of Elanco Animal Health Assets
Via Benzinga
3 Undervalued Blue-Chip Stocks Ready for a Big Comeback
Via InvestorPlace
Merck Animal Health Completes Acquisition of Elanco’s Aqua Business
From Merck & Co., Inc.
Via Business Wire
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Via Benzinga
Topics ETFs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.